CLINICAL TRIALS PROFILE FOR LUMASON
✉ Email this page to a colleague
All Clinical Trials for LUMASON
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT02282163 ↗ | Evaluation of Safety and Efficacy of Lumason in Pediatric Echocardiography | Terminated | Bracco Diagnostics, Inc | Phase 3 | 2015-10-01 | Safety and Efficacy Study in pediatric subjects aged 9 to 17 years of age with suboptimal LV EBD on non-contrast 2D echocardiography. Imaging modalities that are used throughout the study in pediatric subjects represented those utilized in routine clinical practice in adults. |
| NCT02522481 ↗ | Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-141 | Completed | Bracco Diagnostics, Inc | Phase 3 | 2015-09-24 | The purpose of this study was to assess the safety and efficacy of Lumason-enhanced dobutamine stress echo (CE-DSE) in subjects having a suboptimal left ventricular endocardial border delineation (LV EBD) at rest and who were scheduled for coronary angiography. |
| NCT02552238 ↗ | Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-142 | Completed | Bracco Diagnostics, Inc | Phase 3 | 2015-10-12 | The purpose of this study was to assess the safety and efficacy of Lumason-enhanced dobutamine stress echo (DSE) in subjects having a suboptimal left ventricular endocardial border delineation (LV EBD) at rest and who were scheduled for coronary angiography. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for LUMASON
Condition Name
Clinical Trial Locations for LUMASON
Trials by Country
Clinical Trial Progress for LUMASON
Clinical Trial Phase
Clinical Trial Sponsors for LUMASON
Sponsor Name
